234080 — JW Life Science Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩176bn
- KR₩236bn
- KR₩222bn
- 83
- 91
- 83
- 98
Annual cashflow statement for JW Life Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 16,867 | 12,914 | 14,961 | 28,144 | 43,988 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 25,231 | 18,358 | 14,665 | 3,500 | -6,310 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -8,824 | -14,328 | -30,430 | -9,577 | -2,701 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 45,497 | 30,165 | 14,129 | 37,574 | 50,690 |
| Capital Expenditures | -14,980 | -19,396 | -8,293 | -8,267 | -10,307 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -21,323 | -3,409 | -19,954 | 16,303 | -57,727 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -36,303 | -22,805 | -28,247 | 8,037 | -68,034 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -16,463 | -5,029 | 13,115 | -29,308 | 1,776 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7,269 | 2,331 | -1,003 | 16,302 | -15,568 |